Back to today’s briefing

Story perspectives

Biopreservation Market Set to Double by 2029

5/6/2025

25 2

Summary

Biopreservation Market Surge

The global biopreservation market is poised for remarkable growth, soaring from $3.7 billion in 2022 to an impressive $7.1 billion by 2029. This surge is fueled by the rising need for organ transplants and cell therapies. North America stands at the forefront, bolstered by robust healthcare spending and strategic government investments, with industry giants like Thermo Fisher and Merck leading the charge.

Summary

Dermatology Therapy Boom

The dermatological cell and gene therapy market is set to soar, with projections indicating a remarkable 31.3% annual growth rate, potentially hitting $1.5 billion by 2030. Innovations like Krystal Biotech's Vyjuvek, the groundbreaking redosable gene therapy approved in May 2023, are driving this surge, especially for dystrophic epidermolysis bullosa (DEB), which could account for over 80% of market revenue.

1 of 2

Biopreservation Market Surge

The global biopreservation market is poised for remarkable growth, soaring from $3.7 billion in 2022 to an impressive $7.1 billion by 2029. This surge is fueled by the rising need for organ transplants and cell therapies. North America stands at the forefront, bolstered by robust healthcare spending and strategic government investments, with industry giants like Thermo Fisher and Merck leading the charge.

1 / 2